EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 174 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $11,000 | 0.0% | 186 | 0.0% | 0.00% | – |
| Q3 2019 | $11,000 | -21.4% | 186 | -24.7% | 0.00% | – |
| Q2 2019 | $14,000 | +16.7% | 247 | 0.0% | 0.00% | – |
| Q1 2019 | $12,000 | -7.7% | 247 | -24.2% | 0.00% | – |
| Q4 2018 | $13,000 | -7.1% | 326 | +56.0% | 0.00% | – |
| Q3 2018 | $14,000 | +7.7% | 209 | +24.4% | 0.00% | – |
| Q2 2018 | $13,000 | +225.0% | 168 | +147.1% | 0.00% | – |
| Q1 2018 | $4,000 | +100.0% | 68 | +151.9% | 0.00% | – |
| Q3 2017 | $2,000 | -91.7% | 27 | -91.0% | 0.00% | – |
| Q2 2017 | $24,000 | -4.0% | 300 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $25,000 | -47.9% | 300 | -50.0% | 0.00% | 0.0% |
| Q4 2016 | $48,000 | +14.3% | 600 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $42,000 | +82.6% | 600 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $23,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |